Quarterly report pursuant to Section 13 or 15(d)

Collaboration and Research Arrangements - Schedule of Change in Accounts Receivable, Contract Assets and Liabilities (Details)

v3.23.2
Collaboration and Research Arrangements - Schedule of Change in Accounts Receivable, Contract Assets and Liabilities (Details)
$ in Thousands
6 Months Ended
Jun. 30, 2023
USD ($)
Disaggregation Of Revenue [Line Items]  
Contract liabilities, Balance at Beginning of Period $ 4,330
Contract liabilities, Additions 122
Contract liabilities, Deductions (2,267)
Contract liabilities, Balance at End of Period 2,185
Global Blood Therapeutics  
Disaggregation Of Revenue [Line Items]  
Contract liabilities, Balance at Beginning of Period 4,330
Contract liabilities, Additions 122
Contract liabilities, Deductions (2,267)
Contract liabilities, Balance at End of Period $ 2,185